News Focus
News Focus
Followers 22
Posts 4065
Boards Moderated 0
Alias Born 10/12/2013

Re: Whalatane post# 101099

Friday, 02/24/2017 7:02:00 PM

Friday, February 24, 2017 7:02:00 PM

Post# of 447258

Co is immediately cash flow positive if R-IT is stopped at Interim 2, as it will no longer have the cash burn of running the trial.




That's a tad optimistic.... There will be a wind down of operations and possibly some contractual stuff to deal with. Also a lot depends on if the Co/FDA feels that there are questions or data that they'd have liked to see with a full term study or a longer tracking of the Reduce It population in an open label extension of the study.

Or you will be right on since there will be good news and the drug is already available with a pipeline/inventory in place.

But there then will be hand wringing over sales/promotion/staffing/domestic and international distribution and production ramp up expenses replacing Reduce It expenses...

High grade problems to be sure. Depends if immediately means a month or a coupla quarters...

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News